| Effects of Music and Conversation in Prostate Biopsy (NCT07006779) | Bozok University | 2021-06-01 |
| A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer (NCT04633252) | National Cancer Institute (NCI) | 2021-02-23 |
| Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment (NCT03531827) | National Cancer Institute (NCI) | 2019-03-26 |
| PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors (NCT03685591) | Pfizer | 2018-10-04 |
| A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment (NCT03572387) | Icahn School of Medicine at Mount Sinai | 2018-08-20 |
| Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy (NCT03388619) | National Cancer Institute (NCI) | 2018-01-17 |
| Fusion Guided Focal Laser Ablation of Prostate Cancer (NCT02759744) | National Institutes of Health Clinical Center (CC) | 2017-10-13 |
| CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (NCT02900248) | CureOne | 2017-10-02 |
| 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer (NCT03181867) | National Cancer Institute (NCI) | 2017-08-03 |
| Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer (NCT04703543) | Regina Elena Cancer Institute | 2017-06-22 |
| 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer (NCT03173924) | National Cancer Institute (NCI) | 2017-06-06 |
| Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer (NCT02649855) | National Cancer Institute (NCI) | 2016-01-19 |
| Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer (NCT02334579) | Swedish Medical Center | 2014-12-01 |
| Prostate Cancer Stereotactic Radiotherapy (NCT02319239) | Tampere University Hospital | 2014-05-01 |
| Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer (NCT01692483) | Janssen Pharmaceutica | 2013-07-01 |
| A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC) (NCT01715285) | Janssen Research & Development, LLC | 2013-02-12 |
| A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy (NCT01695135) | Janssen Research & Development, LLC | 2012-08-09 |
| Sipuleucel-T Manufacturing Demonstration Study (NCT01477749) | Dendreon | 2012-06-01 |
| Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer (NCT01581749) | Albert DeNittis | 2011-10-01 |
| A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01424930) | Janssen-Ortho Inc., Canada | 2011-10-01 |
| A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT01400555) | Cougar Biotechnology, Inc. | 2011-09-01 |
| A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer (NCT01228760) | Astellas Pharma Inc | 2010-10-01 |
| Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator (NCT00999960) | Assistance Publique - Hôpitaux de Paris | 2010-02-01 |
| A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01017939) | Janssen Research & Development, LLC | 2010-01-01 |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer (NCT00970203) | Roswell Park Cancer Institute | 2009-09-01 |
| A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer (NCT00972309) | National Cancer Institute (NCI) | 2009-05-11 |
| A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT00910754) | Janssen Research & Development, LLC | 2009-05-01 |
| CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution (NCT00643994) | Accuray Incorporated | 2007-12-01 |
| CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry (NCT00643617) | Accuray Incorporated | 2007-10-22 |
| An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma (NCT00544440) | Janssen Research & Development, LLC | 2007-10-01 |
| A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer (NCT00600535) | Cougar Biotechnology, Inc. | 2007-07-01 |
| An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 (NCT01664728) | Janssen Research & Development, LLC | 2007-04-01 |
| An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy (NCT00474383) | Cougar Biotechnology, Inc. | 2006-11-01 |
| Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer (NCT00298155) | University of Washington | 2006-07-01 |
| Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer (NCT00473746) | Janssen Research & Development, LLC | 2006-06-01 |
| Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer (NCT00167648) | University of Washington | 2005-03-01 |
| Use of Tracking Devices to Locate Abnormalities During Invasive Procedures (NCT00102544) | National Institutes of Health Clinical Center (CC) | 2005-02-23 |
| PS-341 Followed by Removal of Prostate for Those With Prostate Cancer (NCT00425503) | Baylor College of Medicine | 2001-12-01 |
| Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer (NCT01217697) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01834209) | Janssen Research & Development, LLC | |